Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: Study protocol for a randomized controlled trial

Trials

Volumn 16, Issue 1, 2015, Pages

  El Hajj, Maguy Saffouh ^a   Kheir, Nadir ^a   Al Mulla, Ahmad Mohd ^b   Al Badriyeh, Daoud ^a   Al Kaddour, Ahmad ^a   Mahfoud, Ziyad R ^c,d   Salehi, Mohammad ^e   Fanous, Nadia ^b  

^a College of Pharmacy ^*  (Qatar)

^b HAMAD MEDICAL CORPORATION   (Qatar)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^e Qatar University   (Qatar)

Author keywords

Pharmacist; Qatar; Smoking cessation; Tobacco control

Indexed keywords

CARBON MONOXIDE; NICOTINE PATCH;

ADULT; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; HEALTH CARE DELIVERY; HUMAN; MEDICAL PRACTICE; NICOTINE REPLACEMENT THERAPY; PHARMACIST; PHARMACY; PROSPECTIVE STUDY; QATAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESOURCE MANAGEMENT; SMOKING CESSATION; SMOKING CESSATION PROGRAM; ADOLESCENT; CLINICAL PROTOCOL; MALE; OUTCOME ASSESSMENT; SAMPLE SIZE;

ADOLESCENT; CLINICAL PROTOCOLS; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACISTS; PROSPECTIVE STUDIES; QATAR; SAMPLE SIZE; SMOKING CESSATION;

EID: 84924914227     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-0570-z     Document Type: Article

References (50)

1. Lande G. Nicotine addiction. [http://emedicine.medscape.com/article/287555-overview]
2. The World Health Organization. The top 10 causes of death Fact sheet [http://www.who.int/mediacentre/factsheets/fs310/en/index2.html]
3. The World Health Organization: Tobacco [http://www.who.int/mediacentre/factsheets/fs339/en/index.html]
4. The World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008 The MPOWER package [http://whqlibdoc.who.int/publications/2008/9789241596282_eng.pdf]
5. Center for Disease Control and Prevention: Smoking and Tobacco Use Cessation and Interventions [http://www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/quitting/index.htm]
6. Roth MT, Andrus MR, Westman EC. Outcomes from an outpatient smoking cessation clinic. Pharmacotherapy. 2005;25(2):279-88.
7. The World Health Organization: Tobacco Free Initiative [http://www.who.int/tobacco/research/economics/cessation/en/index.html]
8. Canadian Pharmacists Association. Joint Statement on Smoking Cessation- Tobacco the Role of Health Professionals in Smoking Cessation [http://www.pharmacists.ca/cpha-ca/assets/File/cpha-on-the-issues/PPSmokingCessation.pdf]
9. Hudmon KS, Prokhorov AV, Corelli RS. Tobacco cessation counseling: pharmacists' opinions and practices. Patient Educ Couns. 2006;61:152-60.
10. Aquilino ML, Farris KB, Zillich AJ, Lowe JB. Smoking-cessation services in Iowa community pharmacies. Pharmacotherapy. 2003;23(5):666-73.
11. Sinclair HK, Bond CM, Stead LF. Community pharmacy personnel interventions for smoking cessation. Cochrane Database Syst Rev. 2004, Issue 1. Art. No.: CD003698. doi: 10.1002/14651858.CD003698.pub2.
12. Maguire TA, McElnay JC, Drummond A. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction. 2001;96(2):325-31.
13. Vial RJ, Jones TE, Ruffin RE, Gilbert AL. Smoking cessation program using nicotine patches: linking hospital to the community. J Pharm Pract Res. 2002;32:57-62.
14. Carroll P, Rois R, Sarson D, Flynn J. A community pharmacy based smoking cessation program using transdermal nicotine replacement therapy: actions and outcomes. Aust Pharmacist. 2000;19:51-5.
15. Sinclair HK, Bond CM, Lennox AS, Silcock J, Winfield AJ, Donnan PT. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomized controlled trial in Scotland. Tob Control. 1998;7:253-61.
16. Zillich AJ, Ryan M, Adams A, Yeager B, Farris K. Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality of life. Pharmacotherapy. 2002;22:759-65.
17. Dent LA, Harris KJ, Noonan CW. Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation. Ann Pharmacother. 2009;43(2):194-201.
18. Smith MD, McGhan WF, Lauger G. Pharmacist counseling and outcomes of smoking cessation. Am Pharm. 1995;NS35(8):20-9.
19. Kennedy DT, Giles JT, Chang ZG, Small RE, Edwards JH. Results of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc (Wash). 2002;42:51-6.
20. Dent LA, Scott JG, Lewis E. Pharmacist-managed tobacco cessation program in Veterans Health Administration community-based outpatient clinic. J Am Pharm Assoc (Wash DC). 2004;44:700-15.
21. Crealey GE, McElnay JC, Maguire TA, O'Neill C. Costs and effects associated with a community pharmacy-based smoking-cessation programme. Pharmacoeconomics. 1998;14(3):323-33.
22. McGhan WF, Smith MD. Pharmacoeconomic analysis of smoking cessation interventions. Am J Health Syst Pharm. 1996;53(1):45-52.
23. Sinclair HK, Silcock J, Bond CM, Lennox AS, Winfield AJ. The cost-effectiveness of intensive pharmaceutical intervention in assisting people to stop smoking. Int J Pharm Pract. 1999;7:107-12.
24. Tran MT, Holdford DA, Kennedy DT, Small RE. Modeling the cost-effectiveness of a smoking cessation program in a community pharmacy practice. Pharmacotherapy. 2002;22(2):1623-31.
25. FIP Statement of Policy: the Role of the Pharmacist in Promoting a Tobacco Free Future. [https://www.fip.org/files/fip/news/tobacco-final2.pdf]
26. European Forum Pharmacists' Charter on Action against Smoking [http://www.europharmforum.org/file/13612]
27. 2008 PHS Guideline Update Panel, Liaisons, and Staff. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care. 2008;53(9):1217-22.
28. Hudmon KS, Corelli RL. ASHP therapeutic position statement on the cessation of tobacco Use. Am J Health Syst Pharm. 2009;66:291-307.
29. Al-Kuwari MG. Tobacco control in Qatar. Middle East J Fam Med. 2008;6(6):11-3.
30. Al-Mulla A, Bener A. Cigarette smoking habits among Qatari population. Public Health Med. 2003;4(3):41-4.
31. Global Youth Tobacco Surveillance, 2000-2007 [http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5701a1.htm]
32. Bener A, Zirie M, Kim EJ, Buz R, Zaza M, Nufal, et al. Measuring burden of diseases in a rapidly developing economy: state of Qatar. Glob J Health Sci. 2013;5(2):134-44.
33. Ibrahim WH, Rasul KI, Khinji A, Ahmed MS, Bener A. Clinical and epidemiological characteristics of lung cancer cases in Qatar. East Mediterr Health J. 2010;16(2):166-70.
34. Smoking-Addressing a National Epidemic [https://qatar-weill.cornell.edu/media/intoHealth/SmokingEpidemic.html]
35. El Hajj M, Al-Nakeeb R, Al-Qudah R. Smoking cessation counseling in Qatar: community Pharmacists' attitudes, role perceptions, and practices. Int J Clin Pharm. 2012;34(4):667-76. doi: 10.1007/s11096-012-9663-x.
36. Smoking cessation clinic [http://stopsmoking.hamad.qa/ar/clinic/clinic.aspx]
37. Sackey JA. Smoking cessation counseling strategies in primary care. [http://www.uptodate.com/contents/smoking-cessation-counseling-strategies-in-primary-care?source=search_result&search=Smoking+cessation+counseling+strategies+in+primary+care&selectedTitle=1150]
38. Kennedy DT, Small RE. Development and implementation of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc. 2002;42(1):83-92.
39. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict. 1991;86(9):1119-27.
40. Al Mohamed HI, Amin TT. Pattern and prevalence of smoking among students at King Faisal University, Al Hassa, Saudi Arabia. EMHJ. 2010;16(1):56-64.
41. Asfar MD, Vander MW, Maziak W, Hammal F, Eissenberg T, Ward KD. Outcomes and adherence in Syria's first smoking cessation trial. Am J Health Behav. 2008;32(2):146-56.
42. Olufade AO, Shaw JW, Foster SA, Leischow SJ, Hays RD, Coons SJ. Development of the smoking cessation quality of life questionnaire. Clin Ther. 1999;21(12):2113-30.
43. Smoking Cessation Quality of Life (SCQoL) Questionnaire [http://qol.thoracic.org/sections/instruments/pt/pages/scqol.html]
44. Hudmon KS, Berger BA. Pharmacy applications of the transtheoretical model in smoking cessation. Am J Health Syst Pharm. 1995;52:282-7.
45. DRUGDEX® Evaluations: Nicotine [http://www.micromedexsolutions.com/home/dispatch]
46. DRUGDEX® Evaluations: Nicotine polacrilex [http://www.micromedexsolutions.com/home/dispatch]
47. Jatlow P, Toll BA, Leary V, Krishnan-Sarin S, O'Malley SS. Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence. Drug Alcohol Depend. 2008;98(3):203-9.
48. Borelli B, Hogan J, Bock B, Pinto B, Roberts M, Marcus B. Predictors of quitting and dropout among women in a clinic-based smoking cessation program. Psychol Addict Behav. 2002;16(1):22-7.
49. Though the smoke: Tobacco use in the Middle East [http://www.ispu.org/Getpolicy/34/1846/Publications.aspx]
50. Kheir N, Zaidan M, Younes H, El Hajj M, Wilbur K, Jewesson PJ. Pharmacy education and practice in 13 Middle Eastern countries. Am J Pharm Educ. 2008;72(6):1-13.